Literature DB >> 28386796

Management of Peyronie's disease - a review.

Hari Siva Gurunadha Rao Tunuguntla1.   

Abstract

Peyronie's disease is an uncommon condition involving middle-aged men and probably resulting from penile trauma. The injury causes an inflammation in the tunica and ultimately scarring and penile curvature develop. It may also occur due to nonspecific inflammation. The use of medications such as β-blockers can sometimes result in Peyronie's disease. In Peyronie's disease, the normal elastic tissue of the tunica is replaced by scar tissue. The penile plaque, or scar tissue in this condition, is not elastic but hard and will not stretch with erection. The side that does not stretch results in penile curvature to the side of the scar. One third of men with Peyronie's disease have painful erections. A low percentage of men with Peyronie's disease develop erectile dysfunction. Because inflammation is initially associated with the scar tissue, some amount of discomfort occurs during erection. Most patients with early stage Peyronie's disease can continue to function sexually with the curvature in the penis. Others with a severe penile deformity will have difficulty in sexual intercourse. Literature regarding the effectiveness of conservative therapy in the early phase with pain and inflammation is limited, with only modest and at times anecdotal benefits. The commonly used agents include 400 units of vitamin E (vitamin E promotes healing and prevents scarring), ibuprofen (anti-inflammatory) and Colchicine (useful for pain during erection). Fexofenadine is recently being used in the early phase of Peyronie's disease for its anti-inflammatory effect. Radiation and ultrasound are not usually very helpful. When the disease process stops, there is usually some residual distortion of the penis but the majority of patients are able to have satisfactory sexual intercourse. However, if there is severe penile distortion interfering with intercourse, surgery is indicated. Surgical techniques for Peyronie's disease include tightening or plication (Nesbit's tuck) of the penis opposite the curvature to produce straightening. This usually results in some small loss of length. The other type of surgery consists of incision of the plaque or scar tissue and patching with a vein (saphenous vein graft) or dermal graft. Laser therapy is occasionally used. A penile prosthesis is the treatment of choice in patients with Peyronie's disease and erectile dysfunction.

Entities:  

Year:  2001        PMID: 28386796     DOI: 10.1007/s003450100209

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  7 in total

1.  Plaque incision and venous patch grafting for Peyronie's disease.

Authors:  Ahmet Metin; Onder Kayigil; S Iftekhar Ahmed
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 2.  Ultrasound in patients affected with Peyronie's disease.

Authors:  P Fornara; H-P Gerbershagen
Journal:  World J Urol       Date:  2004-07-28       Impact factor: 4.226

Review 3.  [Use of free dermal grafts in urology].

Authors:  H Sperling; G Lümmen; S Krege; H Rübben
Journal:  Urologe A       Date:  2005-07       Impact factor: 0.639

4.  [Reconstructive urology in transition. From its origin into the all too near future].

Authors:  K-D Sievert; J Seibold; D Schultheiss; G Feil; H Sperling; M Fisch; A Stenzl
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

5.  Development of a biomarker database toward performing disease classification and finding disease interrelations.

Authors:  Shaikh Farhad Hossain; Ming Huang; Naoaki Ono; Aki Morita; Shigehiko Kanaya; Md Altaf-Ul-Amin
Journal:  Database (Oxford)       Date:  2021-03-11       Impact factor: 3.451

6.  The effectiveness of transdermal electromotive administration with verapamil and dexamethasone in the treatment of Peyronie's disease.

Authors:  Can Tuygun; Ugur Hakki Ozok; Adnan Gucuk; I Halil Bozkurt; M Abdurrahim Imamoglu
Journal:  Int Urol Nephrol       Date:  2008-07-01       Impact factor: 2.370

7.  Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study.

Authors:  M Shirazi; A R Haghpanah; M Badiee; M A Afrasiabi; S Haghpanah
Journal:  Int Urol Nephrol       Date:  2009-02-06       Impact factor: 2.370

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.